The Postoperative Pain Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details. 

“Postoperative Pain Pipeline Insight, 2023“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Postoperative Pain Market.

Some of the key takeaways from the Postoperative Pain Pipeline Report:

• Companies across the globe are diligently working toward developing novel Postoperative Pain treatment therapies with a considerable amount of success over the years. 
• Postoperative Pain companies working in the treatment market are InSitu Biologics, Bexson Biomedical, Allay Therapeutics, SiteOne Therapeutics, LipoCure, Flexion Therapeutics, Nevakar, Inc., Jiangsu HengRui Medicine Co., Ltd., Concentric Analgesics, Oculis Pharma, Haisco Pharmaceutical Group, Vivozon Pharmaceutical Inc, and others, are developing therapies for the Postoperative Pain treatment 

• Emerging Postoperative Pain therapies in the different phases of clinical trials are- INSB-200, BB-106, ATX-201, ST-2427, LC-400, FX 301, NVK-009, HR021618, CA-008, OCS-01, HSK21542, VVZ-149, and others are expected to have a significant impact on the Postoperative Pain market in the coming years.  
• In January 2021, Additional encouraging outcomes from Concentric Analgesics’ Phase II clinical trial including vocacapsaicin (CA008), a first-in-class, non-opioid medication with FDA Breakthrough Therapy Designation, were revealed. The study examined the impact of 187 patients undergoing total knee arthroplasty (“TKA”) on safety, vocacapsaicin pharmacokinetics, opioid usage, and reported pain during a 28-day period.

Postoperative Pain Overview

Because it results from surgical trauma, postoperative pain is categorized as an acute pain type that is accompanied by inflammation and the start of an afferent neuronal barrage.

Get a Free Sample PDF Report to know more about Postoperative Pain Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/postoperative-pain-pipeline-insight

Emerging Postoperative Pain Drugs Under Different Phases of Clinical Development Include:

• INSB-200: InSitu Biologics
• BB-106: Bexson Biomedical
• ATX-201: Allay Therapeutics
• ST-2427: SiteOne Therapeutics
• LC-400: LipoCure
• FX 301: Flexion Therapeutics
• NVK-009: Nevakar, Inc.
• HR021618: Jiangsu HengRui Medicine Co., Ltd.
• CA-008: Concentric Analgesics
• OCS-01: Oculis Pharma
• HSK21542: Haisco Pharmaceutical Group
• VVZ-149: Vivozon Pharmaceutical Inc

Postoperative Pain Route of Administration

Postoperative Pain pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as 

• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical

Postoperative Pain Molecule Type

Postoperative Pain Products have been categorized under various Molecule types, such as

• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy 

Postoperative Pain Pipeline Therapeutics Assessment

• Postoperative Pain Assessment by Product Type
• Postoperative Pain By Stage and Product Type
• Postoperative Pain Assessment by Route of Administration
• Postoperative Pain By Stage and Route of Administration
• Postoperative Pain Assessment by Molecule Type
• Postoperative Pain by Stage and Molecule Type

DelveInsight’s Postoperative Pain Report covers around 50+ products under different phases of clinical development like

• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Postoperative Pain product details are provided in the report. Download the Postoperative Pain pipeline report to learn more about the emerging Postoperative Pain therapies

Some of the key companies in the Postoperative Pain Therapeutics Market include:

Key companies developing therapies for Postoperative Pain are – Novartis AG, Allergan plc, Teva Pharmaceutical, Mylan N.V., Pfizer, Purdue Pharma, Janssen Pharmaceuticals, Inc., Endo International plc., Pacira Pharmaceuticals Inc., Egalet Corporation, GlaxoSmithKline Plc., and others

Postoperative Pain Pipeline Analysis:

The Postoperative Pain pipeline report provides insights into 

• The report provides detailed insights about companies that are developing therapies for the treatment of Postoperative Pain with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Postoperative Pain Treatment.
• Postoperative Pain key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Postoperative Pain Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. 
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Postoperative Pain market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Postoperative Pain drugs and therapies

Postoperative Pain Pipeline Market Drivers

• Rise in the number of surgical procedures worldwide, government’s initiative to promote better postoperative pain treatment are some of the important factors that are fueling the Postoperative Pain Market.

Postoperative Pain Pipeline Market Barriers

• However, adverse effects associated with the medications, research Gaps in Practice Guidelines for Acute Postoperative Pain Management and other factors are creating obstacles in the Postoperative Pain Market growth.

Scope of Postoperative Pain Pipeline Drug Insight    

• Coverage: Global
• Key Postoperative Pain Companies: InSitu Biologics, Bexson Biomedical, Allay Therapeutics, SiteOne Therapeutics, LipoCure, Flexion Therapeutics, Nevakar, Inc., Jiangsu HengRui Medicine Co., Ltd., Concentric Analgesics, Oculis Pharma, Haisco Pharmaceutical Group, Vivozon Pharmaceutical Inc, and others
• Key Postoperative Pain Therapies: INSB-200, BB-106, ATX-201, ST-2427, LC-400, FX 301, NVK-009, HR021618, CA-008, OCS-01, HSK21542, VVZ-149, and others
• Postoperative Pain Therapeutic Assessment: Postoperative Pain current marketed and Postoperative Pain emerging therapies
• Postoperative Pain Market Dynamics: Postoperative Pain market drivers and Postoperative Pain market barriers 

Request for Sample PDF Report for Postoperative Pain Pipeline Assessment and clinical trials

Table of Contents

1. Postoperative Pain Report Introduction

2. Postoperative Pain Executive Summary

3. Postoperative Pain Overview

4. Postoperative Pain- Analytical Perspective In-depth Commercial Assessment

5. Postoperative Pain Pipeline Therapeutics

6. Postoperative Pain Late Stage Products (Phase II/III)

7. Postoperative Pain Mid Stage Products (Phase II)

8. Postoperative Pain Early Stage Products (Phase I)

9. Postoperative Pain Preclinical Stage Products

10. Postoperative Pain Therapeutics Assessment

11. Postoperative Pain Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Postoperative Pain Key Companies

14. Postoperative Pain Key Products

15. Postoperative Pain Unmet Needs

16 . Postoperative Pain Market Drivers and Barriers

17. Postoperative Pain Future Perspectives and Conclusion

18. Postoperative Pain Analyst Views

19. Appendix

20. About DelveInsight

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email: Send Email
Phone: 8774225362
Address:27 Drydock Ave S. Jones Blvd #2432
City: Boston
State: MA
Country: United States
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services